Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer

DMM Disease Models and Mechanisms

Volumn 4, Issue 2, 2011, Pages 165-178

  Cox, Thomas R ^a   Erler, Janine T ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPIONITRILE; CATHEPSIN; COLLAGEN TYPE 1; DISINTEGRIN; FIBRONECTIN; HEPARIN LYASE; INTEGRIN; MATRIX METALLOPROTEINASE; OSTEONECTIN; PROTEIN LYSINE 6 OXIDASE; THROMBOSPONDIN;

ANIMAL MODEL; ATOMIC FORCE MICROSCOPY; BASEMENT MEMBRANE; BIOCHEMICAL COMPOSITION; BONE DISEASE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CELL COMPOSITION; CELL CULTURE; CELL FUNCTION; CELLULAR STRESS RESPONSE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ELASTOGRAPHY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCATION; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CIRRHOSIS; LUNG FIBROSIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OSTEOLATHYRISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVIEW; RIGIDITY; SYSTEMIC SCLEROSIS; TARGET CELL DESTRUCTION; TISSUE; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR GROWTH; TUMOR MICROENVIRONMENT; VISCOELASTICITY;

ANIMALS; CELLS; EXTRACELLULAR MATRIX; FIBROSIS; HOMEOSTASIS; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASMS;

EID: 79952340427     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.004077     Document Type: Review

References (177)

1. Abraham, D. J. and Varga, J. (2005). Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 26, 587-595. (Pubitemid 41726446)
2. Aggarwal, B. B. and Gehlot, P. (2009). Inflammation and cancer: how friendly is the relationship for cancer patients? Curr. Opin. Pharmacol. 9, 351-369.
3. Ahn, G. O. and Brown, J. M. (2008). Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13, 193-205.
4. Akhtar, R., Sherratt, M. J., Watson, R. E., Kundu, T. and Derby, B. (2009a). Mapping the micromechanical properties of cryo-sectioned aortic tissue with scanning acoustic microscopy. Mater. Res. Soc. Symp. Proc. 1132E.
5. Akhtar, R., Schwarzer, N., Sherratt, M. J., Watson, R. E., Graham, H. K., Trafford, A. W., Mummery, P. M. and Derby, B. (2009b). Nanoindentation of histological specimens: mapping the elastic properties of soft tissues. J. Mater. Res. 24, 638-646.
6. Alcaraz, J., Xu, R., Mori, H., Nelson, C. M., Mroue, R., Spencer, V. A., Brownfield, D., Radisky, D. C., Bustamante, C. and Bissell, M. J. (2008). Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J. 27, 2829-2838.
7. Arnold, S. A., Rivera, L. B., Miller, A. F., Carbon, J. G., Dineen, S. P., Xie, Y., Castrillon, D. H., Sage, E. H., Puolakkainen, P., Bradshaw, A. D. et al. (2010). Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma. Dis. Model. Mech. 3, 57-72.
8. Avery, N. C. and Bailey, A. J. (2006). The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol. Biol. (Paris) 54, 387-395. (Pubitemid 44442672)
9. Baker, E. L. and Zaman, M. H. (2010). The biomechanical integrin. J. Biomech. 43, 38-44.
10. Barbone, P. E. and Bamber, J. C. (2002). Quantitative elasticity imaging: what can and cannot be inferred from strain images. Phys. Med. Biol. 47, 2147-2164.
11. Barcellos-Hoff, M. H., Aggeler, J., Ram, T. G. and Bissell, M. J. (1989). Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105, 223-235. (Pubitemid 19053272)
12. Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C. et al. (2010). Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat. Med. 16, 1009-1017.
13. Beloussov, L. V., Louchinskaia, N. N. and Stein, A. A. (2000). Tension-dependent collective cell movements in the early gastrula ectoderm of Xenopus laevis embryos. Dev. Genes Evol. 210, 92-104.
14. Ben-Baruch, A. (2006). The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev. 25, 357-371.
15. Bennewith, K. L., Huang, X., Ham, C. M., Graves, E. E., Erler, J. T., Kambham, N., Feazell, J., Yang, G. P., Koong, A. and Giaccia, A. J. (2009). The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res. 69, 775-784.
16. Berkenblit, A., Matulonis, U. A., Kroener, J. F., Dezube, B. J., Lam, G. N., Cuasay, L. C., Brunner, N., Jones, T. R., Silverman, M. H. and Gold, M. A. (2005). A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Gynecol. Oncol. 99, 50-57.
17. Bilder, D., Li, M. and Perrimon, N. (2000). Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 289, 113-116. (Pubitemid 30463303)
18. Biondi, M. L., Turri, O., Leviti, S., Seminati, R., Cecchini, F., Bernini, M., Ghilardi, G. and Guagnellini, E. (2000). MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin. Chem. 46, 2023-2024.
19. Bird, J. L., Platt, D., Wells, T., May, S. A. and Bayliss, M. T. (2000). Exercise-induced changes in proteoglycan metabolism of equine articular cartilage. Equine Vet. J. 32, 161-163.
20. Birk, D. E. and Bruckner, P. (2005). Collagen Suprastructures. Top. Curr. Biol. 247, 185-205. (Pubitemid 44423501)
21. Bissell, M. J. and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46-54. (Pubitemid 33741880)
22. Boyd, N. F., Dite, G. S., Stone, J., Gunasekara, A., English, D. R., McCredie, M. R., Giles, G. G., Tritchler, D., Chiarelli, A., Yaffe, M. J. et al. (2002). Heritability of mammographic density, a risk factor for breast cancer. N. Engl. J. Med. 347, 886-894.
23. Boyd, N. F., Guo, H., Martin, L. J., Sun, L., Stone, J., Fishell, E., Jong, R. A., Hislop, G., Chiarelli, A., Minkin, S. et al. (2007). Mammographic density and the risk and detection of breast cancer. N. Engl. J. Med. 356, 227-236. (Pubitemid 46143226)
24. Brown, E., McKee, T., diTomaso, E., Pluen, A., Seed, B., Boucher, Y. and Jain, R. K. (2003). Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat. Med. 9, 796-800.
25. Bunn, H. F., Gabbay, K. H. and Gallop, P. M. (1978). The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 200, 21-27.
26. Butcher, D. T., Alliston, T. and Weaver, V. M. (2009). A tense situation: forcing tumour progression. Nat. Rev. Cancer 9, 108-122.
27. Cattell, M. A., Anderson, J. C. and Hasleton, P. S. (1996). Age-related changes in amounts and concentrations of collagen and elastin in normotensive human thoracic aorta. Clin. Chim. Acta 245, 73-84. (Pubitemid 26066919)
28. Chakraborti, S., Mandal, M., Das, S., Mandal, A. and Chakraborti, T. (2003). Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 253, 269-285.
29. Chlenski, A. and Cohn, S. L. (2010). Modulation of matrix remodeling by SPARC in neoplastic progression. Semin. Cell Dev. Biol. 21, 55-65.
30. Condeelis, J. and Pollard, J. W. (2006). Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266.
31. Condeelis, J. and Segall, J. E. (2003). Intravital imaging of cell movement in tumours. Nat. Rev. Cancer 3, 921-930.
32. Cortese, B., Gigli, G. and Riehle, M. (2009). Mechanical gradient cues for guided cell motility and control of cell behavior on uniform substrates. Adv. Funct. Mater. 19, 2961-2968.
33. Coussens, L. M. and Werb, Z. (2001). Inflammatory cells and cancer: think different! J. Exp. Med. 193, F23-F26. (Pubitemid 32524459)
34. Coussens, L. M., Fingleton, B. and Matrisian, L. M. (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392.
35. Csiszar, K. (2001). Lysyl oxidases: a novel multifunctional amine oxidase family. Prog. Nucleic Acid Res. Mol. Biol. 70, 1-32.
36. Denton, C. P. and Abraham, D. J. (2001). Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr. Opin. Rheumatol. 13, 505-511. (Pubitemid 33070969)
37. Derda, R., Laromaine, A., Mammoto, A., Tang, S. K., Mammoto, T., Ingber, D. E. and Whitesides, G. M. (2009). Paper-supported 3D cell culture for tissue-based bioassays. Proc. Natl. Acad. Sci. USA 106, 18457-18462.
38. Desgrosellier, J. S. and Cheresh, D. A. (2010). Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9-22.
39. Discher, D. E., Mooney, D. J. and Zandstra, P. W. (2009). Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673-1677.
40. Dror, Y. and Freedman, M. H. (1999). Shwachman-Diamond syndrome: an inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood 94, 3048-3054.
41. Dufour, A., Sampson, N. S., Zucker, S. and Cao, J. (2008). Role of the hemopexin domain of matrix metalloproteinases in cell migration. J. Cell. Physiol. 217, 643-651.
42. Durier, S., Fassot, C., Laurent, S., Boutouyrie, P., Couetil, J. P., Fine, E., Lacolley, P., Dzau, V. J. and Pratt, R. E. (2003). Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation 108, 1845-1851.
43. Ebihara, T., Venkatesan, N., Tanaka, R. and Ludwig, M. S. (2000). Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Temporal aspects. Am. J. Respir. Crit. Care Med. 162, 1569-1576.
44. Egeblad, M. and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174. (Pubitemid 37328786)
45. Engel, J., Taylor, W., Paulsson, M., Sage, H. and Hogan, B. (1987). Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry 26, 6958-6965.
46. Engler, A. J., Sen, S., Sweeney, H. L. and Discher, D. E. (2006). Matrix elasticity directs stem cell lineage specification. Cell 126, 677-689.
47. Erler, J. T. and Giaccia, A. J. (2008). The cellular microenvironment and metastases. In Abeloff's Clinical Oncology, Fourth Edition (eds M. D. Abeloff, J. O. Armitage, J. E. Niederhuber, M. B. Kastan and W. G. McKenna), pp. 33-47. Philadelphia: Elsevier Publications Ltd. (Churchill Livingstone).
48. Erler, J. T. and Linding, R. (2010). Network-based drugs and biomarkers. J. Pathol. 220, 290-296.
49. Erler, J. T. and Weaver, V. M. (2009). Three-dimensional context regulation of metastasis. Clin. Exp. Metastasis 26, 35-49.
50. Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhofer, N., Kong, C., Le, Q. T., Chi, J. T., Jeffrey, S. S. and Giaccia, A. J. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222-1226.
51. Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q. T. and Giaccia, A. J. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44.
52. Frank, R. N. (1991). On the pathogenesis of diabetic retinopathy. A 1990 update. Ophthalmology 98, 586-593.
53. Friedman, S. L. (2004). Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 1, 98-105.
54. Friedman, S. L., Maher, J. J. and Bissell, D. M. (2000). Mechanisms and therapy of hepatic fibrosis: report of the AASLD single topic basic research conference. Hepatology 32, 1403-1408.
55. Funk, S. E. and Sage, E. H. (1991). The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88, 2648-2652.
56. Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S. and Sahai, E. (2009). Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 11, 1287-1296.
57. Giancotti, F. G. and Ruoslahti, E. (1999). Integrin signaling. Science 285, 1028-1032.
58. Glasheen, B. M., Kabra, A. T. and Page-McCaw, A. (2009). Distinct functions for the catalytic and hemopexin domains of a Drosophila matrix metalloproteinase. Proc. Natl. Acad. Sci. USA 106, 2659-2664.
59. Glenn, J. V. and Stitt, A. W. (2009). The role of advanced glycation end products in retinal ageing and disease. Biochim. Biophys. Acta 1790, 1109-1116.
60. Goffin, J. R., Anderson, I. C., Supko, J. G., Eder, J. P., Jr, Shapiro, G. I., Lynch, T. J., Shipp, M., Johnson, B. E. and Skarin, A. T. (2005). Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. Clin. Cancer Res. 11, 3417-3424.
61. Graham, H. K., Hodson, N. W., Hoyland, J. A., Millward-Sadler, S. J., Garrod, D., Scothern, A., Griffiths, C. E., Watson, R. E., Cox, T. R., Erler, J. T. et al. (2010). Tissue section AFM: In situ ultrastructural imaging of native biomolecules. Matrix Biol. 29, 254-260.
62. Gueta, R., Barlam, D., Shneck, R. Z. and Rousso, I. (2006). Measurement of the mechanical properties of isolated tectorial membrane using atomic force microscopy. Proc. Natl. Acad. Sci. USA 103, 14790-14795. (Pubitemid 44527807)
63. Hadjipanayi, E., Mudera, V. and Brown, R. A. (2009). Guiding cell migration in 3D: a collagen matrix with graded directional stiffness. Cell Motil. Cytoskeleton 66, 121-128.
64. Hasegawa, M., Fujimoto, M., Takehara, K. and Sato, S. (2005). Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J. Dermatol. Sci. 39, 1-7. (Pubitemid 40835827)
65. Hicke, B. J., Stephens, A. W., Gould, T., Chang, Y. F., Lynott, C. K., Heil, J., Borkowski, S., Hilger, C. S., Cook, G., Warren, S. et al. (2006). Tumor targeting by an aptamer. J. Nucl. Med. 47, 668-678. (Pubitemid 46768469)
66. Hornstra, I. K., Birge, S., Starcher, B., Bailey, A. J., Mecham, R. P. and Shapiro, S. D. (2003). Lysyl oxidase is required for vascular and diaphragmatic development in mice. J. Biol. Chem. 278, 14387-14393.
67. Hynes, R. O. (2009). The extracellular matrix: not just pretty fibrils. Science 326, 1216-1219.
68. Ingman, W. V., Wyckoff, J., Gouon-Evans, V., Condeelis, J. and Pollard, J. W. (2006). Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev. Dyn. 235, 3222-3229.
69. Iredale, J. P. (2007). Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 117, 539-548.
70. Issa, R., Zhou, X., Constandinou, C. M., Fallowfield, J., Millward-Sadler, H., Gaca, M. D., Sands, E., Suliman, I., Trim, N., Knorr, A. et al. (2004). Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126, 1795-1808. (Pubitemid 38736345)
71. Jacobs, T. W., Byrne, C., Colditz, G., Connolly, J. L. and Schnitt, S. J. (1999). Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N. Engl. J. Med. 340, 430-436. (Pubitemid 29084774)
72. Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A. and Tsien, R. Y. (2004). Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc. Natl. Acad. Sci. USA 101, 17867-17872.
73. Jodele, S., Blavier, L., Yoon, J. M. and DeClerck, Y. A. (2006). Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev. 25, 35-43.
74. Kagan, H. M. (1994). Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol. Res. Pract. 190, 910-919.
75. Kagan, H. M. (2000). Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis. Acta Trop. 77, 147-152.
76. Kagan, H. M. and Li, W. (2003). Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J. Cell. Biochem. 88, 660-672. (Pubitemid 36258816)
77. Kaler, S. G., Gallo, L. K., Proud, V. K., Percy, A. K., Mark, Y., Segal, N. A., Goldstein, D. S., Holmes, C. S. and Gahl, W. A. (1994). Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat. Genet. 8, 195-202.
78. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A. et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827. (Pubitemid 41753060)
79. Kass, L., Erler, J. T., Dembo, M. and Weaver, V. M. (2007). Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int. J. Biochem. Cell Biol. 39, 1987-1994.
80. Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J. and Wynn, T. A. (2004). IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 173, 4020-4029.
81. Keeley, E. C., Mehrad, B. and Strieter, R. M. (2009). Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosis. Int. J. Biochem. Cell Biol. 42, 535-542.
82. Kessenbrock, K., Plaks, V. and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
83. Kirschmann, D. A., Seftor, E. A., Fong, S. F., Nieva, D. R., Sullivan, C. M., Edwards, E. M., Sommer, P., Csiszar, K. and Hendrix, M. J. (2002). A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62, 4478-4483. (Pubitemid 34827311)
84. Klotzsch, E., Smith, M. L., Kubow, K. E., Muntwyler, S., Little, W. C., Beyeler, F., Gourdon, D., Nelson, B. J. and Vogel, V. (2009). Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites. Proc. Natl. Acad. Sci. USA 106, 18267-18272.
85. Korosoglou, G., Weiss, R. G., Kedziorek, D. A., Walczak, P., Gilson, W. D., Schar, M., Sosnovik, D. E., Kraitchman, D. L., Boston, R. C., Bulte, J. W. et al. (2008). Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J. Am. Coll. Cardiol. 52, 483-491.
86. Kumar, S. and Weaver, V. M. (2009). Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev. 28, 113-127.
87. Lane, T. F. and Sage, E. H. (1994). The biology of SPARC, a protein that modulates cellmatrix interactions. FASEB J. 8, 163-173.
88. Le, Q. T., Kong, C., Lavori, P. W., O'Byrne, K., Erler, J. T., Huang, X., Chen, Y., Cao, H., Tibshirani, R., Denko, N. et al. (2007). Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 69, 167-175. (Pubitemid 47247510)
89. Le, Q. T., Harris, J., Magliocco, A. M., Kong, C. S., Diaz, R., Shin, B., Cao, H., Trotti, A., Erler, J. T., Chung, C. H. et al. (2009). Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: radiation therapy oncology group trial 90-03. J. Clin. Oncol. 27, 4281-4286.
90. Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F., Csiszar, K., Giaccia, A., Weninger, W. et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906.
91. Li, R. K., Li, G., Mickle, D. A., Weisel, R. D., Merante, F., Luss, H., Rao, V., Christakis, G. T. and Williams, W. G. (1997). Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96, 874-881.
92. Littlepage, L. E., Sternlicht, M. D., Rougier, N., Phillips, J., Gallo, E., Yu, Y., Williams, K., Brenot, A., Gordon, J. I. and Werb, Z. (2010). Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res. 70, 2224-2234.
93. Lo, C. M., Wang, H. B., Dembo, M. and Wang, Y. L. (2000). Cell movement is guided by the rigidity of the substrate. Biophys. J. 79, 144-152.
94. Low, A. F., Tearney, G. J., Bouma, B. E. and Jang, I. K. (2006). Technology Insight: optical coherence tomography-current status and future development. Nat. Clin. Pract. Cardiovasc. Med. 3, 154-162.
95. Mack, G. S. and Marshall, A. (2010). Lost in migration. Nat. Biotechnol. 28, 214-229.
96. Maki, J. M., Rasanen, J., Tikkanen, H., Sormunen, R., Makikallio, K., Kivirikko, K. I. and Soininen, R. (2002). Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106, 2503-2509. (Pubitemid 35278809)
97. Markiewicz, M., Smith, E. A., Rubinchik, S., Dong, J. Y., Trojanowska, M. and LeRoy, E. C. (2004). The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts. Clin. Exp. Rheumatol. 22, S31-S34.
98. Massague, J. (2008). TGFbeta in Cancer. Cell 134, 215-230.
99. McAteer, M. A., Schneider, J. E., Ali, Z. A., Warrick, N., Bursill, C. A., von zur Muhlen, C., Greaves, D. R., Neubauer, S., Channon, K. M. and Choudhury, R. P. (2008). Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler. Thromb. Vasc. Biol. 28, 77-83.
100. McPhail, L. D. and Robinson, S. P. (2010). Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis. Radiology 254, 110-118.
101. Michigami, T., Shimizu, N., Williams, P. J., Niewolna, M., Dallas, S. L., Mundy, G. R. and Yoneda, T. (2000). Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. Blood 96, 1953-1960. (Pubitemid 30661083)
102. Miserus, R. J., Herias, M. V., Prinzen, L., Lobbes, M. B., Van Suylen, R. J., Dirksen, A., Hackeng, T. M., Heemskerk, J. W., van Engelshoven, J. M., Daemen, M. J. et al. (2009). Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent. JACC Cardiovasc. Imaging 2, 987-996.
103. Mitsiades, N., Yu, W. H., Poulaki, V., Tsokos, M. and Stamenkovic, I. (2001). Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res. 61, 577-581. (Pubitemid 32128617)
104. Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A. and Toews, G. B. (2005). CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am. J. Pathol. 166, 675-684.
105. Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M. and Fidler, I. J. (1988). Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 48, 6863-6871. (Pubitemid 19012219)
106. Mosher, D. F. and Schad, P. E. (1979). Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. J. Clin. Invest. 64, 781-787.
107. Mosher, D. F., Schad, P. E. and Kleinman, H. K. (1979). Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines. J. Supramol. Struct. 11, 227-235.
108. Mossman, B. T. and Churg, A. (1998). Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157, 1666-1680.
109. Mott, J. D. and Werb, Z. (2004). Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564. (Pubitemid 39201241)
110. Moustakas, A. and Heldin, C. H. (2005). Non-Smad TGF-beta signals. J. Cell Sci. 118, 3573-3584.
111. Murawaki, Y., Kusakabe, Y. and Hirayama, C. (1991). Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin. Hepatology 14, 1167-1173.
112. Murphy-Ullrich, J. E., Lane, T. F., Pallero, M. A. and Sage, E. H. (1995). SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand. J. Cell. Biochem. 57, 341-350.
113. Muthuswamy, S. K., Li, D., Lelievre, S., Bissell, M. J. and Brugge, J. S. (2001). ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3, 785-792. (Pubitemid 32842683)
114. Oldberg, A., Kalamajski, S., Salnikov, A. V., Stuhr, L., Morgelin, M., Reed, R. K., Heldin, N. E. and Rubin, K. (2007). Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. Proc. Natl. Acad. Sci. USA 104, 13966-13971. (Pubitemid 350003321)
115. Pampaloni, F., Reynaud, E. G. and Stelzer, E. H. (2007). The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8, 839-845.
116. Pardo, A. and Selman, M. (2006). Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc. Am. Thorac. Soc. 3, 383-388. (Pubitemid 43845417)
117. Paszek, M. J. and Weaver, V. M. (2004). The tension mounts: mechanics meets morphogenesis and malignancy. J. Mammary Gland Biol. Neoplasia 9, 325-342.
118. Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D. et al. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254. (Pubitemid 41317594)
119. Pawson, T. and Linding, R. (2008). Network medicine. FEBS Lett. 582, 1266-1270.
120. Payne, S. L., Fogelgren, B., Hess, A. R., Seftor, E. A., Wiley, E. L., Fong, S. F., Csiszar, K., Hendrix, M. J. and Kirschmann, D. A. (2005). Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 65, 11429-11436.
121. Payne, S. L., Hendrix, M. J. and Kirschmann, D. A. (2007). Paradoxical roles for lysyl oxidases in cancer-a prospect. J. Cell. Biochem. 101, 1338-1354.
122. Perentes, J. Y., McKee, T. D., Ley, C. D., Mathiew, H., Dawson, M., Padera, T. P., Munn, L. L., Jain, R. K. and Boucher, Y. (2009). In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts. Nat. Methods 6, 143-145.
123. Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P. and Strieter, R. M. (2004). Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438-446.
124. Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G. and Keely, P. J. (2006). Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4, 38.
125. Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Knittel, J. G., Yan, L., Rueden, C. T., White, J. G. and Keely, P. J. (2008). Collagen density promotes mammary tumor initiation and progression. BMC Med. 6, 11.
126. Radermacher, K. A., Beghein, N., Boutry, S., Laurent, S., Vander Elst, L., Muller, R. N., Jordan, B. F. and Gallez, B. (2009). In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy. Invest. Radiol. 44, 398-404.
127. Radisky, D., Hagios, C. and Bissell, M. J. (2001). Tumors are unique organs defined by abnormal signaling and context. Semin. Cancer Biol. 11, 87-95. (Pubitemid 32423284)
128. Reardon, D. A., Zalutsky, M. R., Akabani, G., Coleman, R. E., Friedman, A. H., Herndon, J. E., 2nd, McLendon, R. E., Pegram, C. N., Quinn, J. A., Rich, J. N. et al. (2008). A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost. Neuro. Oncol. 10, 182-189.
129. Reynolds, P. R., Larkman, D. J., Haskard, D. O., Hajnal, J. V., Kennea, N. L., George, A. J. and Edwards, A. D. (2006). Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 241, 469-476.
130. Rittweger, J., Winwood, K., Seynnes, O., de Boer, M., Wilks, D., Lea, R., Rennie, M. and Narici, M. (2006). Bone loss from the human distal tibia epiphysis during 24 days of unilateral lower limb suspension. J. Physiol. 577, 331-337. (Pubitemid 44698259)
131. Rittweger, J., Simunic, B., Bilancio, G., De Santo, N. G., Cirillo, M., Biolo, G., Pisot, R., Eiken, O., Mekjavic, I. B. and Narici, M. (2009). Bone loss in the lower leg during 35 days of bed rest is predominantly from the cortical compartment. Bone 44, 612-618.
132. Rocco, P. R., Negri, E. M., Kurtz, P. M., Vasconcellos, F. P., Silva, G. H., Capelozzi, V. L., Romero, P. V. and Zin, W. A. (2001). Lung tissue mechanics and extracellular matrix remodeling in acute lung injury. Am. J. Respir. Crit. Care Med. 164, 1067-1071.
133. Rosenbaum, E., Zahurak, M., Sinibaldi, V., Carducci, M. A., Pili, R., Laufer, M., DeWeese, T. L. and Eisenberger, M. A. (2005). Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial. Clin. Cancer Res. 11, 4437-4443.
134. Rosenkranz, S., Flesch, M., Amann, K., Haeuseler, C., Kilter, H., Seeland, U., Schluter, K. D. and Bohm, M. (2002). Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am. J. Physiol. Heart Circ. Physiol. 283, H1253-H1262.
135. Roskelley, C. D., Srebrow, A. and Bissell, M. J. (1995). A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr. Opin. Cell Biol. 7, 736-747.
136. Royce, P. M., Camakaris, J. and Danks, D. M. (1980). Reduced lysyl oxidase activity in skin fibroblasts from patients with Menkes' syndrome. Biochem. J. 192, 579-586.
137. Roycik, M. D., Fang, X. and Sang, Q. X. (2009). A fresh prospect of extracellular matrix hydrolytic enzymes and their substrates. Curr. Pharm. Des. 15, 1295-1308.
138. Sage, H., Johnson, C. and Bornstein, P. (1984). Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J. Biol. Chem. 259, 3993-4007.
139. Sage, H., Vernon, R. B., Funk, S. E., Everitt, E. A. and Angello, J. (1989). SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix. J. Cell Biol. 109, 341-356.
140. Sakamoto, T. and Seiki, M. (2009). Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity. Genes Cells 14, 617-626.
141. Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., Koike, T., Wakayama, I., Yanagihara, R., Garruto, R. et al. (1998). Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am. J. Pathol. 153, 1149-1155. (Pubitemid 28465838)
142. Scherer, R. L., McIntyre, J. O. and Matrisian, L. M. (2008a). Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev. 27, 679-690.
143. Scherer, R. L., VanSaun, M. N., McIntyre, J. O. and Matrisian, L. M. (2008b). Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol. Imaging 7, 118-131.
144. Schmeichel, K. L. and Bissell, M. J. (2003). Modeling tissue-specific signaling and organ function in three dimensions. J. Cell Sci. 116, 2377-2388. (Pubitemid 36790120)
145. Schnider, S. L. and Kohn, R. R. (1980). Glucosylation of human collagen in aging and diabetes mellitus. J. Clin. Invest. 66, 1179-1181.
146. Schwartz, M. A. and Baron, V. (1999). Interactions between mitogenic stimuli, or, a thousand and one connections. Curr. Opin. Cell Biol. 11, 197-202. (Pubitemid 29164034)
147. Sethi, T., Rintoul, R. C., Moore, S. M., MacKinnon, A. C., Salter, D., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S. C., Strieter, R. et al. (1999). Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 5, 662-668. (Pubitemid 29289430)
148. Sherratt, M. J., Baldock, C., Haston, J. L., Holmes, D. F., Jones, C. J., Shuttleworth, C. A., Wess, T. J. and Kielty, C. M. (2003). Fibrillin microfibrils are stiff reinforcing fibres in compliant tissues. J. Mol. Biol. 332, 183-193.
149. Sivakumar, P., Gupta, S., Sarkar, S. and Sen, S. (2008). Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy. Mol. Cell. Biochem. 307, 159-167. (Pubitemid 350238658)
150. Sivan, S. S., Wachtel, E., Tsitron, E., Sakkee, N., van der Ham, F., Degroot, J., Roberts, S. and Maroudas, A. (2008). Collagen turnover in normal and degenerate human intervertebral discs as determined by the racemization of aspartic acid. J. Biol. Chem. 283, 8796-8801.
151. Spuentrup, E., Buecker, A., Katoh, M., Wiethoff, A. J., Parsons, E. C., Jr, Botnar, R. M., Weisskoff, R. M., Graham, P. B., Manning, W. J. and Gunther, R. W. (2005). Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 111, 1377-1382.
152. Sternlicht, M. D. and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516. (Pubitemid 33096184)
153. Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J. P., Gray, J. W., Pinkel, D., Bissell, M. J. and Werb, Z. (1999). The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137-146. (Pubitemid 29344902)
154. Stover, D. G., Bierie, B. and Moses, H. L. (2007). A delicate balance: TGF-beta and the tumor microenvironment. J. Cell. Biochem. 101, 851-861.
155. Stracke, C. P., Katoh, M., Wiethoff, A. J., Parsons, E. C., Spangenberg, P. and Spuntrup, E. (2007). Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent. Stroke 38, 1476-1481. (Pubitemid 46684148)
156. Strieter, R. M., Gomperts, B. N. and Keane, M. P. (2007). The role of CXC
157. Strongin, A. Y. (2006). Mislocalization and unconventional functions of cellular MMPs in cancer. Cancer Metastasis Rev. 25, 87-98.
158. Suki, B. and Bates, J. H. (2008). Extracellular matrix mechanics in lung parenchymal diseases. Respir. Physiol. Neurobiol. 163, 33-43.
159. Termine, J. D., Belcourt, A. B., Conn, K. M. and Kleinman, H. K. (1981). Mineral and collagen-binding proteins of fetal calf bone. J. Biol. Chem. 256, 10403-10408.
160. Tsien, R. Y. (2005). Building and breeding molecules to spy on cells and tumors. FEBS Lett. 579, 927-932.
161. Varga, J. and Abraham, D. (2007). Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117, 557-567. (Pubitemid 46348510)
162. Vaupel, P., Kallinowski, F. and Okunieff, P. (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465. (Pubitemid 20008770)
163. Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J. N., Lyons, T. J., Bijlsma, J. W., Lafeber, F. P., Baynes, J. W. and TeKoppele, J. M. (2000). Effect of collagen turnover on the accumulation of advanced glycation end products. J. Biol. Chem. 275, 39027-39031.
164. Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K. and Cerami, A. (1994). Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 4766-4770. (Pubitemid 24177730)
165. Watanabe, T., Barker, T. A. and Berk, B. C. (2005). Angiotensin II and the endothelium: diverse signals and effects. Hypertension 45, 163-169.
166. Weaver, V. M., Fischer, A. H., Peterson, O. W. and Bissell, M. J. (1996). The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell Biol. 74, 833-851.
167. Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C. and Bissell, M. J. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137, 231-245.
168. Wells, R. G. and Discher, D. E. (2008). Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet. Sci. Signal. 1, pe13.
169. Wiberg, C., Klatt, A. R., Wagener, R., Paulsson, M., Bateman, J. F., Heinegard, D. and Morgelin, M. (2003). Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem. 278, 37698-37704. (Pubitemid 37175294)
170. Wipff, P. J., Rifkin, D. B., Meister, J. J. and Hinz, B. (2007). Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 179, 1311-1323. (Pubitemid 350277747)
171. Wolf, K., Alexander, S., Schacht, V., Coussens, L. M., von Andrian, U. H., van Rheenen, J., Deryugina, E. and Friedl, P. (2009). Collagen-based cell migration models in vitro and in vivo. Semin. Cell Dev. Biol. 20, 931-941.
172. Wolfe, J. N. (1976a). Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37, 2486-2492.
173. Wolfe, J. N. (1976b). Breast patterns as an index of risk for developing breast cancer. AJR Am. J. Roentgenol. 126, 1130-1137.
174. Wong, J. Y., Velasco, A., Rajagopalan, P. and Pham, Q. (2003). Directed movement of vascular smooth muscle cells on gradient-compliant hydrogels. Langmuir 19, 1908-1913.
175. Wynn, T. A. (2007). Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117, 524-529.
176. Yamada, K. M. and Cukierman, E. (2007). Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601-610. (Pubitemid 47268064)
177. Yu, H., Mouw, J. K. and Weaver, V. M. (2010). Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol. 21, 47-56.